Picture of Bionexus Gene Lab logo

BGLC Bionexus Gene Lab Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Annual cashflow statement for Bionexus Gene Lab, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.1240.026-0.2461.090.752
Depreciation
Non-Cash Items0.012-0.7350.029
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.439-0.341-0.0240.102-0.862
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities0.357-0.274-0.2170.5530.009
Capital Expenditures-0.315-0.04-0.013-0.422-0.003
Purchase of Fixed Assets
Other Investing Cash Flow Items-5-0.01201.74-0.487
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-5.31-0.052-0.0131.32-0.491
Financing Cash Flow Items0.5770.001-0.0010-0.002
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities5.780.743-0.181-0.005-0.028
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.8390.421-0.4011.93-0.664

Or unlock with your email

Or unlock with your email